Paper30716481
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
Kumar P and 2 others. Semin Cancer Biol, 2020. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis. Papers, record 30716481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30716481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Immunological | Major topic |
| Autoimmune Diseases | Major topic |
| Immunotherapy | Major topic |
| Neoplasms | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| B7-H1 Antigen | |
| CTLA-4 Antigen | |
| Homeostasis | |
| Humans |
Source PubMed
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42982819 | The chromatin-organizer Satb1 modulates regulatory T cell activity within the tumor microenvironment. | Nat Commun | 2026 | https://conductscience.org/library/papers/42982819 | PubMed |
| 42960125 | Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42960125 | PubMed |
| 42908539 | Clinicopathologic characteristics and diagnostic value of PD-L1 in immune checkpoint inhibitor-related liver injury: a single-center retrospective study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42908539 | PubMed |
| 42769860 | From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42769860 | PubMed |
| 42688372 | Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42688372 | PubMed |
| 42653263 | Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653263 | PubMed |
| 42421963 | Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42421963 | PubMed |
| 41988173 | Integrated risk stratification for ICI-associated myocarditis: a baseline hematological profile and a combined ECG and enzymatic signature at onset. | Front Immunol | 2026 | https://conductscience.org/library/papers/41988173 | PubMed |
| 41972182 | Reversing chemoresistance in ovarian cancer: network pharmacology reveals how hydroxychloroquine/sulfasalazine duotherapy remodels tumor inflammatory-immune microenvironment. | Front Immunol | 2026 | https://conductscience.org/library/papers/41972182 | PubMed |
| 41836384 | Single-cell profiling of PBMCS reveals an immune signature of irAEs in anti-PD-1-treated acral melanoma patients. | Front Immunol | 2026 | https://conductscience.org/library/papers/41836384 | PubMed |
| 41306369 | Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024). | J Clin Transl Hepatol | 2025 | https://conductscience.org/library/papers/41306369 | PubMed |
| 41026295 | Role of interleukin-6 in resistance to tumor therapy. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41026295 | PubMed |
| 40842015 | Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40842015 | PubMed |
| 40267151 | Pan-cancer analysis and validation show GTF2E2's diagnostic, prognostic, and immunological roles in regulating ferroptosis in endometrial cancer. | PLoS One | 2025 | https://conductscience.org/library/papers/40267151 | PubMed |
| 40071935 | Structural investigation of an RNA device that regulates PD-1 expression in mammalian cells. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40071935 | PubMed |
| 40051755 | The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides. | Mol Cell Oncol | 2025 | https://conductscience.org/library/papers/40051755 | PubMed |
| 39868913 | Immune-Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges. | Liver Int | 2025 | https://conductscience.org/library/papers/39868913 | PubMed |
| 39832113 | Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy. | Discov Oncol | 2025 | https://conductscience.org/library/papers/39832113 | PubMed |
| 39788584 | [Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma ( version 2024)]. | Zhonghua Gan Zang Bing Za Zhi | 2024 | https://conductscience.org/library/papers/39788584 | PubMed |
| 39719469 | Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy. | Med Oncol | 2024 | https://conductscience.org/library/papers/39719469 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30716481
GET https://conductscience.org/api/papers/v1/30716481/cited_by?page=2